D bioprinted nerve tissues offer new hope for ALS drug testing. Uppsala team creates motor neuron organoids from patient ...

D printers can be used to make organoids from a patient's cells that resemble human nerve tissue to test new amyotrophic lateral sclerosis treatments.

"It's important for research and drug testing to be able to print a large number of organoids in a reproducible way. Our method also makes it possible to include other types of nerve cells ...

With the aid of a 3D printer, researchers at Uppsala University have succeeded in creating a model that resembles human nerve tissue. The model, which can be cultured from the patient’s own ...

New nanobody-based method, POD-nAb/FT-GO 3D-IHC, enables ultra-fast, high-resolution labeling of neurons and glia deep within 1-mm-thick brain tissue, revealing cellular structures in just three days.

More information: Asma Harun et al, 3D Tumor-Mimicking Phantom Models for Assessing NIR I/II Nanoparticles in Fluorescence-Guided Surgical Interventions, ACS Nano (2025). DOI: 10.1021/acsnano.5c01919 ...

The field of 3D bioprinting technology is witnessing rapid advancements, offering new possibilities in regenerative medicine, tissue engineering, and pharmaceutical research.

Motor neurons are nerve cells that control our muscles by sending signals from the brain and spinal cord out to the body. In diseases such as Amyotrophic Lateral Sclerosis (ALS), these cells are ...

With the aid of a 3D printer, researchers at Uppsala University have succeeded in creating a model that resembles human nerve tissue. The model, which can be cultured from the patient's own cells ...

In mammals, olfactory sensory neurons (OSNs) are born throughout life, ostensibly solely to replace neurons lost via turnover or injury. This assumption follows from the hypothesis that olfactory ...

A new study published in Science has found that neurons in the brain do not follow a single strategy when learning. Instead, different parts of the same neuron—its upper and lower branches ...

Multiple sclerosis (MS) affects an estimated 2.3 million people worldwide. Approximately 80% of people with MS have inflammation in the cerebellum, the part of the brain that helps control movement ...